Publications by authors named "Jane Melling"

Claim this Profile
T
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases.
Alina Buture, Esther M Tomkins, Arif Shukralla, Emma Troy, Katie Conaty, Jane Melling

Cephalalgia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17-30 months.
Emma Troy, Arif A Shrukalla, Alina Buture, Katie Conaty, Esther Macken, Jane Melling

J Headache Pain· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Emer Joyce, Eoin Mulroy, Jaqueline Scott, Jane Melling, Carole Goggin

J Card Fail· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosis.
Eoin Mulroy, Emer Joyce, Jaqueline Scott, Jane Melling, Carole Goggin

Eur Neurol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis